Considering that our subjects were overweight or obese and displayed several characteristics of metabolic syndrome, the reduction in TCA metabolites during n-3 FA supplementation may indicate a greater efficiency of the TCA cycle, possibly due to improvements in mitochondrial function or insulin sensitivity. The gene discussed is INS; the disease is metabolic syndrome.